CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C07204 | BRD-K15285842 | BRD-K15285842 | -- | -- | -- | Details |
| C07205 | BRD-K15290974 | BRD-K15290974 | -- | -- | -- | Details |
| C07206 | BRD-K15291808 | BRD-K15291808 | -- | -- | -- | Details |
| C07207 | BRD-K15293421 | BRD-K15293421 | -- | -- | -- | Details |
| C07208 | BRD-K15300571 | BRD-K15300571 | -- | -- | -- | Details |
| C07209 | BRD-K15318079 | BRD-K15318079 | -- | -- | -- | Details |
| C07210 | BRD-K15318383 | BRD-K15318383 | -- | -- | ammonium-glycyrrhizinate | Details |
| C07211 | BRD-K15318909 | PRIMA1 | ACHE | TP53 inhibitor | PRIMA-1 | Details |
| C07212 | BRD-K15322427 | BRD-K15322427 | -- | -- | -- | Details |
| C07213 | BRD-K15328325 | BRD-K15328325 | -- | -- | -- | Details |
| C07214 | BRD-K15341710 | BRD-K15341710 | -- | -- | -- | Details |
| C07215 | BRD-K15343038 | BRD-K15343038 | -- | -- | -- | Details |
| C07216 | BRD-K15343767 | BRD-K15343767 | -- | -- | -- | Details |
| C07217 | BRD-K15350548 | BRD-K15350548 | -- | -- | -- | Details |
| C07218 | BRD-K15358569 | BRD-K15358569 | -- | -- | -- | Details |
| C07219 | BRD-K15373812 | BRD-K15373812 | -- | -- | -- | Details |
| C07220 | BRD-K15377376 | BRD-K15377376 | -- | -- | -- | Details |
| C07221 | BRD-K15378071 | BRD-K15378071 | -- | -- | 2-(4-methylphenoxy)-N-(4-[1,3]oxazolo[4,5-b]pyridin-2-ylphenyl)acetamide | Details |
| C07222 | BRD-K15380586 | BRD-K15380586 | -- | -- | -- | Details |
| C07223 | BRD-K15380626 | BRD-K15380626 | -- | -- | -- | Details |
| C07224 | BRD-K15384215 | BRD-K15384215 | -- | -- | -- | Details |
| C07225 | BRD-K15387690 | BRD-K15387690 | -- | -- | -- | Details |
| C07226 | BRD-K15389388 | BRD-K15389388 | -- | -- | -- | Details |
| C07227 | BRD-K15389391 | BRD-K15389391 | -- | -- | -- | Details |
| C07228 | BRD-K15392449 | SA-1457187 | -- | -- | -- | Details |
| C07229 | BRD-K15393664 | BRD-K15393664 | -- | -- | -- | Details |
| C07230 | BRD-K15400067 | BRD-K15400067 | -- | -- | -- | Details |
| C07231 | BRD-K15400899 | BRD-K15400899 | -- | -- | -- | Details |
| C07232 | BRD-K15401903 | BRD-K15401903 | -- | -- | -- | Details |
| C07233 | BRD-K15402119 | huperzine-a | ACHE | Glutamate receptor antagonist; Acetylcholinesterase inhibitor | -- | Details |
| C07234 | BRD-K15409150 | penfluridol | -- | -- | -- | Details |
| C07235 | BRD-K15410616 | BRD-K15410616 | -- | -- | -- | Details |
| C07236 | BRD-K15414305 | BRD-K15414305 | -- | -- | -- | Details |
| C07237 | BRD-K15418616 | BRD-K15418616 | -- | -- | -- | Details |
| C07238 | BRD-K15419449 | I-303059 | -- | -- | -- | Details |
| C07239 | BRD-K15419834 | BRD-K15419834 | -- | -- | -- | Details |
| C07240 | BRD-K15419902 | BRD-K15419902 | -- | -- | -- | Details |
| C07241 | BRD-K15420741 | BRD-K15420741 | -- | -- | -- | Details |
| C07242 | BRD-K15424032 | SB-228357 | HTR2C | Serotonin receptor antagonist | -- | Details |
| C07243 | BRD-K15426076 | iguratimod | PTGS2 | NFKB pathway inhibitor; Cyclooxygenase inhibitor | -- | Details |
| C07244 | BRD-K15426523 | BRD-K15426523 | -- | -- | -- | Details |
| C07245 | BRD-K15427120 | BRD-K15427120 | -- | -- | -- | Details |
| C07246 | BRD-K15428056 | BRD-K15428056 | -- | -- | -- | Details |
| C07247 | BRD-K15433418 | BRD-K15433418 | -- | -- | -- | Details |
| C07248 | BRD-K15434241 | BRD-K15434241 | -- | -- | -- | Details |
| C07249 | BRD-K15440898 | BRD-K15440898 | -- | -- | -- | Details |
| C07250 | BRD-K15442833 | BRD-K15442833 | -- | -- | -- | Details |
| C07251 | BRD-K15444511 | BRD-K15444511 | -- | -- | -- | Details |
| C07252 | BRD-K15453459 | BRD-K15453459 | -- | -- | -- | Details |
| C07253 | BRD-K15457570 | BRD-K15457570 | -- | -- | -- | Details |
| C07254 | BRD-K15460257 | BRD-K15460257 | -- | -- | -- | Details |
| C07255 | BRD-K15460493 | BRD-K15460493 | -- | -- | -- | Details |
| C07256 | BRD-K15464148 | BRD-K15464148 | -- | -- | -- | Details |
| C07257 | BRD-K15466057 | BRD-K15466057 | -- | -- | -- | Details |
| C07258 | BRD-K15467014 | BRD-K15467014 | -- | -- | -- | Details |
| C07259 | BRD-K15474464 | BRD-K15474464 | -- | -- | -- | Details |
| C07260 | BRD-K15475572 | BRD-K15475572 | -- | -- | -- | Details |
| C07261 | BRD-K15476875 | BRD-K15476875 | -- | -- | -- | Details |
| C07262 | BRD-K15477190 | BRD-K15477190 | -- | -- | -- | Details |
| C07263 | BRD-K15478481 | BRD-K15478481 | -- | -- | -- | Details |
| C07264 | BRD-K15478534 | BRD-K15478534 | -- | -- | -- | Details |
| C07265 | BRD-K15485967 | BRD-K15485967 | -- | -- | -- | Details |
| C07266 | BRD-K15489726 | BRD-K15489726 | -- | -- | -- | Details |
| C07267 | BRD-K15499806 | BRD-K15499806 | -- | -- | -- | Details |
| C07268 | BRD-K15502390 | nevirapine | CYP1A2; CYP2A6; CYP2B6; CYP2C9; CYP2D6; CYP3A4; CYP3A5 | Reverse transcriptase inhibitor | -- | Details |
| C07269 | BRD-K15502712 | BRD-K15502712 | -- | -- | -- | Details |
| C07270 | BRD-K15502859 | BRD-K15502859 | -- | -- | -- | Details |
| C07271 | BRD-K15505145 | BRD-K15505145 | -- | -- | -- | Details |
| C07272 | BRD-K15507118 | BRD-K15507118 | -- | -- | -- | Details |
| C07273 | BRD-K15507868 | tesaglitazar | PPARA; PPARG | Insulin sensitizer; PPAR receptor agonist | -- | Details |
| C07274 | BRD-K15508005 | BRD-K15508005 | -- | -- | -- | Details |
| C07275 | BRD-K15513102 | BRD-K15513102 | -- | -- | -- | Details |
| C07276 | BRD-K15513663 | BRD-K15513663 | -- | -- | -- | Details |
| C07277 | BRD-K15515777 | BRD-K15515777 | -- | -- | -- | Details |
| C07278 | BRD-K15519488 | CS-110266 | -- | -- | -- | Details |
| C07279 | BRD-K15521652 | BRD-K15521652 | -- | -- | -- | Details |
| C07280 | BRD-K15522385 | cinanserin | -- | -- | -- | Details |
| C07281 | BRD-K15523383 | BRD-K15523383 | -- | -- | -- | Details |
| C07282 | BRD-K15524596 | BRD-K15524596 | -- | -- | -- | Details |
| C07283 | BRD-K15525241 | BRD-K15525241 | -- | -- | -- | Details |
| C07284 | BRD-K15525634 | BRD-K15525634 | -- | -- | -- | Details |
| C07285 | BRD-K15530151 | BRD-K15530151 | -- | -- | -- | Details |
| C07286 | BRD-K15531302 | BRD-K15531302 | -- | -- | -- | Details |
| C07287 | BRD-K15532741 | BRD-K15532741 | -- | -- | -- | Details |
| C07288 | BRD-K15535200 | BRD-K15535200 | -- | -- | -- | Details |
| C07289 | BRD-K15559773 | BRD-K15559773 | -- | -- | -- | Details |
| C07290 | BRD-K15563106 | phloretin | -- | -- | -- | Details |
| C07291 | BRD-K15567136 | papaverine | PDE10A | Phosphodiesterase inhibitor | -- | Details |
| C07292 | BRD-K15567837 | clopamide | -- | -- | -- | Details |
| C07293 | BRD-K15574380 | capecitabine | TYMS | DNA synthesis inhibitor; Thymidylate synthase inhibitor | -- | Details |
| C07294 | BRD-K15579005 | BRD-K15579005 | -- | -- | -- | Details |
| C07295 | BRD-K15587941 | BRD-K15587941 | -- | -- | -- | Details |
| C07296 | BRD-K15588452 | R-96544 | HTR2A | Serotonin receptor antagonist | -- | Details |
| C07297 | BRD-K15591233 | BRD-K15591233 | -- | -- | -- | Details |
| C07298 | BRD-K15592317 | CP-466722 | ATM | ATM kinase inhibitor | -- | Details |
| C07299 | BRD-K15593941 | BRD-K15593941 | -- | -- | -- | Details |
| C07300 | BRD-K15594502 | BRD-K15594502 | -- | -- | -- | Details |
| C07301 | BRD-K15600521 | BRD-K15600521 | -- | -- | -- | Details |
| C07302 | BRD-K15600710 | obatoclax | BCL2 | BCL inhibitor | -- | Details |
| C07303 | BRD-K15601958 | SEW-2871 | S1PR1 | Lysophospholipid receptor agonist | -- | Details |